prof. dr. Jan De Bleecker

Journal Article
A1
open access

Should taurine be pursued further as a supportive nutraceutical for Duchenne muscular dystrophy? Gathering evidence in a zebrafish disease model to confirm or refute the benefits : stage 1 Report

Lenie Vanhove (UGent) , Marthe Dias (UGent) , Delphine De Coninck, Charlotte Grootaert (UGent) , Andreja Rajkovic (UGent) , Delfien Syx (UGent) , Arnaud Vanlander (UGent) , Jan De Bleecker (UGent) and Boel De Paepe (UGent)

(2026) FRONTIERS IN NUTRITION. 13.

Add to list

Conference Paper
C3
open access

Safety, efficacy, and QoL impact of long-term efgartigimod PH20SC in participants with gMG : final results of ADAPT-SC+

C Antozzi, R Bhavaraju-Sanka, Jan De Bleecker (UGent) , A Meisel, K Utsugisawa, W Huang, R Jimenez, F Verhamme, L Liu, D Korobko, et al.

(2026) EUROPEAN JOURNAL OF NEUROLOGY. In European Journal of Neurology 33(Supplement 1). p.91-91

Add to list

Genome-wide association study identifies novel risk loci for inclusion body myositis

Nathan Routledge, Alaa Khan, Iwona Skorupinska, Conceicao Bettencourt, Jana Vandrovcova, Matteo Zanovello, Ashirwad Merve, Qiang Gang, Sára Ágnes Nagy, Michael Sinnreich, et al.

(2026) CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. In Clinical and Experimental Rheumatology p.9-10

Add to list

Conference Paper
C3
open access

Long-term safety and efficacy of subcutaneous efgartigimod PH20 for generalized myasthenia gravis : ADAPT-SC+ final results

Carlo Antozzi, Ratna Bhavaraju-Sanka, Jan De Bleecker (UGent) , Andreas Meisel, Kimiaki Utsugisawa, Wan-Yi Huang, Rosa Hermina Jimenez, Fien Verhamme (UGent) , Li Liu, Denis Korobko, et al.

(2026) JOURNAL OF NEUROMUSCULAR DISEASES. In Journal of Neuromuscular Diseases 13(2, Supplement). p.S206-S206

Add to list

Conference Paper
C3
open access

Long-term safety and efficacy of nipocalimab : approximately 2 years follow-up results from vivacity-MG3 open-label extension

Carlo Antozzi, Tuan Vu, Sindhu Ramchandren, Richard Nowak, Constantine Farmakidis, Vera Bril, Jan De Bleecker (UGent) , Huan Yang, Eduard Minks, Jin-Sung Park, et al.

(2026) JOURNAL OF NEUROMUSCULAR DISEASES. In Journal of Neuromuscular Diseases 13(2, Supplement). p.S205-S205

Add to list

Conference Paper
C3
open access

Phase 2/3 study of an investigational anti-inflammatory biologic therapy in inclusion body myositis

Namita Goyal, Pedro Machado, Dana Ascherman, Olivier Benveniste, Said Beydoun, Thomas Brannagan, James Caress, Lisa Christopher-Stine, Michael Collins, Jan De Bleecker (UGent) , et al.

(2026) JOURNAL OF NEUROMUSCULAR DISEASES. In Journal of Neuromuscular Diseases 13(2, Supplement). p.S2-S3

Add to list

Journal Article
A1
open access

Belgian recommendations for tissue diagnosis of amyloidosis

Amélie Dendooven (UGent) , Annelore Vandendriessche (UGent) , Priyanka Joseph Koshy, Frank Timmermans (UGent) , Marijn Speeckaert (UGent) , Nicolas Kint (UGent) , Lucas Van Aelst, Marie-Christiane Vekemans, Nathalie Meuleman, Anne-Catherine Pouleur, et al.

(2026) ACTA CLINICA BELGICA. p.1-14

Add to list

Long-term safety and efficacy of nipocalimab in generalized myasthenia gravis : vivacity-MG3 open-label extension phase results

Carlo Antozzi, Tuan Vu, Sindhu Ramchandren, Richard Nowak, Constantine Farmakidis, Vera Bril, Jan De Bleecker (UGent) , Huan Yang, Eduard Minks, Jin-Sung Park, et al.

(2025) MUSCLE & NERVE. In Muscle & Nerve 72(4). p.1017-1018

Add to list

Overview of the Belgian neuromuscular diseases registry : more than a decade of data

M. Jagut, N. De Meulemeester, J. Baets, D. Beysen, V. Bissay, K. Claeys, A. Daron, Jan De Bleecker (UGent) , N. Deconinck, S. Delstanche, et al.

(2025) NEUROMUSCULAR DISORDERS. In Neuromuscular Disorders 53(Supplement S). p.135-135

Add to list

Long-term safety and efficacy of nipocalimab in generalized myasthenia gravis : vivacity-MG3 open-label extension phase results

K. Borst, C. Antozzi, T. Vu, S. Ramchandren, JR Nowak, C. Farmakidis, V. Bril, Jan De Bleecker (UGent) , H. Yang, E. Minks, et al.

(2025) NEUROMUSCULAR DISORDERS. In Neuromuscular Disorders 53(Supplement S). p.106-106

Academic Bibliography

prof. dr. Jan De Bleecker

Should taurine be pursued further as a supportive nutraceutical for Duchenne muscular dystrophy? Gathering evidence in a zebrafish disease model to confirm or refute the benefits : stage 1 Report

Safety, efficacy, and QoL impact of long-term efgartigimod PH20SC in participants with gMG : final results of ADAPT-SC+

Genome-wide association study identifies novel risk loci for inclusion body myositis

Long-term safety and efficacy of subcutaneous efgartigimod PH20 for generalized myasthenia gravis : ADAPT-SC+ final results

Long-term safety and efficacy of nipocalimab : approximately 2 years follow-up results from vivacity-MG3 open-label extension

Phase 2/3 study of an investigational anti-inflammatory biologic therapy in inclusion body myositis

Belgian recommendations for tissue diagnosis of amyloidosis

Long-term safety and efficacy of nipocalimab in generalized myasthenia gravis : vivacity-MG3 open-label extension phase results

Overview of the Belgian neuromuscular diseases registry : more than a decade of data

Long-term safety and efficacy of nipocalimab in generalized myasthenia gravis : vivacity-MG3 open-label extension phase results

Contents

Support

Contact